
    
      All subjects will have 7 blood samples taken: prior to and one month after vaccination and
      one, two, three, four and five years after vaccination. No new subjects will be enrolled in
      the extension phases of this Phase IIb study.

      The Protocol Posting has been updated in order to comply with the FDA Amendment Act,
      September 2007.
    
  